Dr. Tülay Yarkın
Pulmonology & Thoracic SurgeryVerified
- 28+years exp.
English · Turkish
60 seconds · no obligationView Profile
Robotic lung segmentectomy is an anatomical, parenchymal-sparing thoracic operation that removes a single broncho-vascular lung segment rather than an entire lobe. This guide covers how robotic-assisted segmentectomy works, oncological evidence for early-stage lung cancer, approximate costs in Turkey compared with the UK and US, recovery timelines, procedural risks, and essential standards for choosing a specialised thoracic surgical unit.
A written plan with the surgeon's name and the full price — usually within 24 hours.

1 doctor Compare doctors, ratings and prices — ask any of them for a free quote.
Pulmonology & Thoracic SurgeryVerified
English · Turkish
60 seconds · no obligationView Profile
Robotic lung segmentectomy is an anatomical thoracic operation that removes a single broncho-vascular segment of the lung rather than an entire lobe. Unlike a non-anatomical wedge resection that simply removes a wedge of tissue, a segmentectomy dissects and divides the specific segmental pulmonary artery branch, pulmonary vein tributary, and tertiary bronchus. Unlike a full lobectomy, it preserves the surrounding healthy lung tissue within the same lobe, protecting vital breathing capacity. Thoracic surgeons perform the procedure using high-definition robotic consoles with micro-articulated instruments.
Hospitals in Turkey frequently perform robotic thoracic surgery for international patients with small, peripheral lung tumours or solitary pulmonary nodules. The robotic approach offers exceptional precision in deep chest cavities without spreading the ribs. This guide explains how the surgery works, what clinical trials show regarding cancer control, approximate costs compared with the UK and US, recovery timelines, and procedural safety. For related procedures, see our guide to pulmonology treatments in Turkey (hub).
The lungs contain five lobes—three in the right lung and two in the left—which are further divided into eighteen to twenty distinct bronchopulmonary segments. In robotic lung segmentectomy, only the affected segment is excised, leaving adjacent healthy segments functioning normally.
The surgeon sits at an ergonomic console controlling robotic arms that hold specialized instruments. These instruments feature wrist-like articulation with seven degrees of movement, filtering out hand tremor and allowing precise dissection around fragile pulmonary vessels. A 3D camera delivers tenfold magnified views of thoracic structures. To establish the boundary between segments, the surgical team injects indocyanine green (ICG) dye intravenously after securing the segmental vessels. Under near-infrared illumination, perfused healthy segments glow bright green, while the devascularised diseased segment remains dark. The surgeon then divides tissue precisely along this intersegmental plane using robotic staplers.
For decades, lobectomy was the standard surgical treatment for early-stage lung cancer. However, landmark randomised trials—notably JCOG0802/WJOG4607L and CALGB 140503—demonstrated that anatomical segmentectomy yields equivalent cancer control and overall survival to lobectomy for peripheral non-small cell lung cancer (NSCLC) measuring two centimetres or smaller (stage IA), provided regional lymph nodes are clear.
The major benefit of segmentectomy is respiratory preservation. Patients retain roughly 5% to 10% more post-operative lung capacity (measured by FEV1 and FVC) compared with lobectomy, which is critical for individuals with reduced pulmonary reserve or emphysema. Nonetheless, clinical criteria are strict: segmentectomy is not suitable for central lesions, tumours larger than two centimetres without ground-glass characteristics, or cases with lymph node spread. A responsible surgical team confirms eligibility through contrast CT, PET-CT staging, and intraoperative frozen-section margin analysis.
The cost of robotic thoracic surgery depends on the complexity of the resected segment, robotic instrumentation and stapler cartridges used, and the length of inpatient monitoring. The table below outlines approximate price ranges for private self-pay treatment across key countries.
| Country | Approximate cost range |
|---|---|
| Turkey | €9,000 – €18,000 |
| United Kingdom | €18,000 – €35,000 |
| United States | €32,000 – €65,000 |
| Germany | €16,000 – €30,000 |
Specialised robotic consumables, such as wristed instruments and articulating endostaplers, account for a significant portion of the surgical fee. Comprehensive packages in Turkish hospitals typically include pre-operative anaesthetic assessments, surgeon and anaesthetist fees, operating theatre time, three to five nights in hospital (including high-dependency care), routine medications, chest radiography, histopathology, and airport transfers. Additional staging scans or extended intensive care are billed separately if required.
Thoracic surgeons choose the surgical approach based on tumour size, location, and the patient's baseline pulmonary reserve. While segmentectomy preserves parenchyma, larger or centrally located tumours may require a standard lobectomy or, in advanced disease, a pneumonectomy.
| Surgical technique | Best suited to | Typical limits |
|---|---|---|
| Robotic segmentectomy | Peripheral tumours ≤ 2 cm; patients needing lung conservation | Demanding technique; unsuitable for central tumours or nodal spread |
| Robotic lobectomy | Tumours > 2 cm, central lesions, or uncertain surgical margins | Removes 20% to 30% of lung volume; greater loss of functional reserve |
| VATS segmentectomy | Segmental resection using standard video-assisted thoracoscopy | Rigid straight instruments limit manoeuvrability in narrow hilar angles |
| Open thoracotomy | Complex tumours invading chest wall; emergency conversions | Involves rib spreading; leads to longer recovery and higher acute pain |
Compared with conventional VATS, robotic instrumentation provides magnified 3D visualisation and multi-angle articulation around delicate pulmonary arteries. Compared with open thoracotomy, avoiding rib spreading substantially reduces post-operative pain and shortens hospital stay.
A multidisciplinary thoracic team evaluates candidate suitability using anatomical and pulmonary guidelines. Good candidates generally present with:
Conversely, patients are not candidates if tumours are located centrally near lobar bronchus bifurcations, exceed two centimetres with solid features, or show suspected hilar or mediastinal nodal involvement. If intraoperative frozen-section analysis identifies involved lymph nodes or close margins, the surgeon converts the operation to a lobectomy to ensure complete oncological resection.
Robotic lung segmentectomy typically takes between two and three and a half hours under general anaesthesia. The operation follows five core stages:
Undergoing robotic thoracic surgery in Turkey typically involves a trip of eight to eleven days. The recovery process proceeds through clear clinical milestones:
You will be mobilized to sit and walk within 12 to 24 hours of surgery to promote lung expansion and prevent venous thrombosis. A temporary chest drain remains in place, connected to a digital suction device that measures air leaks and fluid drainage. Once fluid output drops below 150–200 ml per day and no air leak is detected—typically on postoperative day two or three—the chest tube is removed. Inpatient hospital stay is usually three to five nights.
Following discharge, you remain in local accommodation for outpatient wound checks and follow-up chest imaging. Once the surgical team confirms satisfactory lung re-expansion and oxygen levels, they issue a fit-to-fly certificate. Patients generally return to desk-based work within three to four weeks, while full stamina returns over six to eight weeks. Daily incentive spirometry exercises are required to support respiratory recovery.
Like any major thoracic procedure, robotic segmentectomy carries potential risks, which are documented in registries by the Society of Thoracic Surgeons (STS) and European Society of Thoracic Surgeons (ESTS).
The most common complication specific to segmentectomy is a prolonged air leak (lasting beyond five days), occurring in approximately 5% to 10% of patients due to dissection along the parenchymal plane. The vast majority resolve with conservative drainage. Other potential complications include chest infection, temporary atelectasis, subcutaneous emphysema, postoperative bleeding, and transient atrial fibrillation. In rare instances of severe adhesions or uncontrolled bleeding, conversion to an open thoracotomy or full lobectomy is necessary. Accredited hospitals mitigate these risks through routine blood-thinning protocols, continuous cardiac monitoring, and dedicated respiratory therapy.
Because lung resection is major oncological surgery, choosing a hospital requires thorough verification of clinical standards rather than commercial promotion.
Ensure the facility is an accredited hospital with an on-site thoracic intensive care unit (ICU) and a multidisciplinary tumour board that reviews every case. Your surgeon should be a board-certified thoracic specialist with verified experience in robotic thoracic consoles. Red flags include medical brokers offering quotes without examining recent high-resolution CT scans, centres lacking emergency thoracic backup, surgeons who cannot verify their robotic case volume, and promises of an effortless or guaranteed recovery. Learn more about how our process works and request an assessment through our free quote form.
Before confirming surgery, consider asking these practical questions during your initial clinical consultation:
Robotic lung segmentectomy is a minimally invasive surgical procedure that removes a single anatomical sub-unit (segment) of a lung lobe along with its individual artery, vein, and bronchus. It uses robotic instruments and 3D magnification to preserve surrounding healthy lung tissue while achieving complete oncological clearance for early-stage lung tumours or nodules.
Yes. Major international randomised trials, including JCOG0802 and CALGB 140503, have confirmed that anatomical segmentectomy provides overall survival and cancer recurrence rates equal to lobectomy for peripheral non-small cell lung cancer measuring two centimetres or smaller, while preserving significantly more post-operative lung function.
Robotic lung segmentectomy in Turkey typically costs between €9,000 and €18,000, compared with €18,000 to €35,000 in the UK and €32,000 to €65,000 in the US. The price depends on the complexity of the segment, robotic stapler consumables, and inpatient hospital care.
Before surgery, patients undergo contrast chest CT, PET-CT staging, and lung function testing. Afterwards, imaging should confirm complete surgical excision with clear margins and full re-expansion of remaining lung tissue. Patients retain higher respiratory capacity and experience less chronic chest wall stiffness than after open surgery.
A lobectomy removes an entire lobe of the lung (20% to 30% of total lung capacity), whereas a segmentectomy removes only the specific diseased anatomical segment. Segmentectomy preserves more healthy breathing tissue, making it preferable for small peripheral tumours or patients with reduced baseline lung capacity.
Because robotic surgery avoids rib spreading or large muscle-cutting incisions, post-operative pain is substantially lower than with traditional open thoracotomy. Patients feel chest wall soreness and discomfort around the port sites and chest drain, which is managed with standard intravenous and oral pain relief.
Most patients stay in hospital for three to five nights and have their chest tube removed after two or three days. Walking begins within 24 hours. Desk-based work can usually be resumed after three to four weeks, while full physical recovery takes six to eight weeks.
When performed by an experienced thoracic surgical team in an accredited hospital with an intensive care unit, robotic segmentectomy is safe. The most common complication is a temporary air leak lasting several days. The risk of major vascular complications or emergency thoracotomy conversion is low.
When performed for small, node-negative lung cancers with clear margins, the resection is definitive. Long-term cancer-free survival matches that of traditional lobectomy. Routine oncological follow-up with periodic low-dose CT scans is maintained for five years to monitor long-term health.
Patients typically spend eight to eleven days in Turkey. This allows one to two days for pre-operative consultations and scans, three to five nights of inpatient hospital care, and several days in local accommodation after chest tube removal to confirm healing before flying home.
Your request is in!
Your coordinator will contact you — usually within 2 hours, 24/7.
Want a faster, more accurate assessment?
Add photos & medical detailsLeave your number — a coordinator calls you in your language, usually within 15 minutes during office hours.
Thank you!
A coordinator will contact you at the time you chose.